Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × INDUSTRY × ONC206 × Clear all

Phase

Status

Recruiting 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Injections 37 Carboplatin 29 Capecitabine 25 Oxaliplatin 24 Paclitaxel 22 Docetaxel 22 Cisplatin 21 Bevacizumab 21 pembrolizumab 19 Pemetrexed 17 Gemcitabine 17 Fluorouracil 12 Cyclophosphamide 12 Irinotecan 11 Leucovorin 9 tislelizumab 8 Nivolumab 8 osimertinib 7 fludarabine 7 Trastuzumab 7 regorafenib 6 lenvatinib 6 Doxorubicin 6 130-nm albumin-bound paclitaxel 6 toripalimab 5 Topotecan 5 Temozolomide 5 Rituximab 5 Platinum 5 Drug Therapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07533942 2026-04-16

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

Jazz Pharmaceuticals

Phase 2 Not yet recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡